XML 76 R64.htm IDEA: XBRL DOCUMENT v3.8.0.1
STOCK-BASED COMPENSATION (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
STOCK-BASED COMPENSATION    
Proceeds from stock option exercises $ 34,880 $ 18,705
Stock options    
STOCK-BASED COMPENSATION    
Award vesting period 3 years  
Expiration period 10 years  
Compensation expense $ 4,900 6,900
Compensation expense, net of tax 3,500 4,600
Income tax benefit related to compensation expense 1,400 2,300
Fair value of shares vested 16,500 16,900
Proceeds from stock option exercises 34,900  
Actual tax benefit realized for the tax deduction from option exercises 6,000  
Unrecognized compensation cost expected to be recognized in future periods $ 17,400  
Weighted-average period over which compensation cost is expected to be recognized 2 years  
Stock options | Selling, research & development and administrative expenses    
STOCK-BASED COMPENSATION    
Compensation expense $ 4,000 6,000
Restricted stock units    
STOCK-BASED COMPENSATION    
Compensation expense 2,600 900
Actual tax benefit realized for the tax deduction from option exercises 383  
Unrecognized compensation cost expected to be recognized in future periods $ 24,400  
Weighted-average period over which compensation cost is expected to be recognized 2 years 8 months 12 days  
Weighted-Average Grant-Date Fair Value    
Fair value of units vested $ 1,000 2,800
Intrinsic value of units vested $ 1,300 $ 3,000
Restricted stock units (time-based)    
STOCK-BASED COMPENSATION    
Award vesting period 3 years  
Restricted stock unit activity    
Balance at the beginning of the period (in shares) 124,067  
Granted (in shares) 80,067  
Vested (in shares) (14,281)  
Balance at the end of the period (in shares) 189,853  
Weighted-Average Grant-Date Fair Value    
Nonvested at the beginning of the period (in dollars per share) $ 74.65  
Granted (in dollars per share) 89.42  
Vested (in dollars per share) 71.72  
Nonvested at the end of the period (in dollars per share) $ 81.10  
Restricted stock units (performance-based)    
STOCK-BASED COMPENSATION    
Award vesting period 3 years  
Assumptions used to estimate fair value of stock options granted    
Dividend Yield (as a percent) 1.43%  
Expected Stock Price Volatility (as a percent) 12.30%  
Risk-free Interest Rate (as a percent) 2.42%  
Assumptions used to estimate fair value of restricted stock units granted    
Fair value per stock award (in dollars per share) $ 128.70  
Grant date stock price (in dollars per share) $ 89.42  
Expected Stock Price Volatility (as a percent) 12.30%  
Expected average volatility of peer companies (as a percent) 27.50%  
Correlation assumption (as a percent) 20.20%  
Risk-free Interest Rate (as a percent) 2.42%  
Dividend Yield (as a percent) 1.43%  
Restricted stock unit activity    
Granted (in shares) 80,843  
Balance at the end of the period (in shares) 80,843  
Weighted-Average Grant-Date Fair Value    
Granted (in dollars per share) $ 111.55  
Nonvested at the end of the period (in dollars per share) 111.55  
Stock Awards Plans | Stock options    
STOCK-BASED COMPENSATION    
Weighted-average fair value of stock options granted (in dollars per share) $ 14.82 $ 11.85
Assumptions used to estimate fair value of stock options granted    
Dividend Yield (as a percent) 1.50% 1.70%
Expected Stock Price Volatility (as a percent) 14.20% 15.80%
Risk-free Interest Rate (as a percent) 2.80% 2.20%
Expected Life of Option (years) 6 years 7 months 6 days 6 years 8 months 12 days
Stock options activity    
Outstanding at the beginning of the period (in shares) 8,059,319  
Granted (in shares) 603,901  
Exercised (in shares) (613,913)  
Forfeited or expired (in shares) (26,738)  
Outstanding at the end of the period (in shares) 8,022,569  
Exercisable at the end of the period (in shares) 5,935,087  
Weighted Average Exercise Price    
Outstanding at the beginning of the period (in dollars per share) $ 61.67  
Granted (in dollars per share) 88.39  
Exercised (in dollars per share) 52.73  
Forfeited or expired (in dollars per share) 63.13  
Outstanding at the end of the period (in dollars per share) 64.36  
Exercisable at the end of the period (in dollars per share) $ 59.55  
Weighted-Average Remaining Contractual Term (Years):    
Outstanding at the end of the period 6 years 4 months 24 days  
Exercisable at the end of the period 5 years 6 months  
Aggregate Intrinsic Value:    
Outstanding at the end of the period $ 204,336  
Exercisable at the end of the period 179,720  
Intrinsic Value of Options Exercised $ 22,804 $ 15,289
Assumptions used to estimate fair value of restricted stock units granted    
Expected Stock Price Volatility (as a percent) 14.20% 15.80%
Risk-free Interest Rate (as a percent) 2.80% 2.20%
Dividend Yield (as a percent) 1.50% 1.70%
Director Stock Option Plans | Stock options    
Stock options activity    
Outstanding at the beginning of the period (in shares) 214,967  
Exercised (in shares) (44,000)  
Outstanding at the end of the period (in shares) 170,967  
Exercisable at the end of the period (in shares) 170,967  
Weighted Average Exercise Price    
Outstanding at the beginning of the period (in dollars per share) $ 57.44  
Exercised (in dollars per share) 53.35  
Outstanding at the end of the period (in dollars per share) 58.49  
Exercisable at the end of the period (in dollars per share) $ 58.49  
Weighted-Average Remaining Contractual Term (Years):    
Outstanding at the end of the period 4 years 10 months 24 days  
Exercisable at the end of the period 4 years 10 months 24 days  
Aggregate Intrinsic Value:    
Outstanding at the end of the period $ 5,358  
Exercisable at the end of the period 5,358  
Intrinsic Value of Options Exercised $ 1,608  
Director Stock Option Plans | Restricted stock units    
STOCK-BASED COMPENSATION    
Award vesting period 1 year  
Director Stock Option Plans | Restricted stock units (time-based)    
Restricted stock unit activity    
Balance at the end of the period (in shares) 14,793  
New long-term incentive program    
STOCK-BASED COMPENSATION    
Compensation expense $ 409 $ 282
Expected total expense related to program over the performance period $ 2,600